EVALPFC2-ICE2PCS01 Infineon Technologies, EVALPFC2-ICE2PCS01 Datasheet - Page 2
![BOARD DEMO 300/500W CCM-PFC SMPS](/photos/9/7/90739/evalpfc2-ice2pcs01_sml.jpg)
EVALPFC2-ICE2PCS01
Manufacturer Part Number
EVALPFC2-ICE2PCS01
Description
BOARD DEMO 300/500W CCM-PFC SMPS
Manufacturer
Infineon Technologies
Datasheet
1.EVALPFC2-ICE2PCS01.pdf
(16 pages)
Specifications of EVALPFC2-ICE2PCS01
Main Purpose
Power Management, Power Factor Correction
Embedded
No
Utilized Ic / Part
ICE2PS01
Primary Attributes
300W, 393V & 750mA Out, 85~265VAC In
Secondary Attributes
Boost Converter, Continuous Conduction Mode
Lead Free Status / RoHS Status
Lead free / RoHS Compliant
Other names
EVALPFC2-ICE2PCS01IN
Edition 2009-10-13
Published by Infineon Technologies Asia Pacific,
168 Kallang Way,
349253 Singapore, Singapore
© Infineon Technologies AP 2004.
All Rights Reserved.
Attention please!
The information herein is given to describe certain components and shall not be considered as a guarantee of
characteristics.
Terms of delivery and rights to technical change reserved.
We hereby disclaim any and all warranties, including but not limited to warranties of non-infringement, regarding
circuits, descriptions and charts stated herein.
Information
For further information on technology, delivery terms and conditions and prices please contact your nearest Infineon
Technologies Office (www.infineon.com).
Warnings
Due to technical requirements components may contain dangerous substances. For information on the types in question
please contact your nearest Infineon Technologies Office.
Infineon Technologies Components may only be used in life-support devices or systems with the express written
approval of Infineon Technologies, if a failure of such components can reasonably be expected to cause the failure of
that life-support device or system, or to affect the safety or effectiveness of that device or system. Life support devices
or systems are intended to be implanted in the human body, or to support and/or maintain and sustain and/or protect
human life. If they fail, it is reasonable to assume that the health of the user or other persons may be endangered.